Open Access 01-12-2022 | Erythropoietin | Correction
Correction to: A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-Alfa) vs. Eprex® in patients with anaemia of chronic renal failure
Published in: BMC Nephrology | Issue 1/2022
Login to get access